Cardiotonic drugs are a class of medications primarily designed to enhance the contractile force of the heart muscle and improve its pumping efficiency. These drugs play a crucial role in the management of various cardiovascular conditions, particularly heart failure. By increasing the strength of each heartbeat, cardiotonic drugs help improve cardiac output, ensuring that the heart effectively pumps blood throughout the body. Digoxin, a well-known cardiotonic drug, is derived from the foxglove plant and has been used for centuries. It works by inhibiting a sodium-potassium pump, leading to an increase in intracellular calcium concentration, which, in turn, strengthens myocardial contractions. While cardiotonic drugs can be beneficial in certain clinical scenarios, their use requires careful monitoring due to the narrow therapeutic window and potential for toxicity. In modern medicine, these drugs are often prescribed in combination with other cardiovascular medications to optimize treatment outcomes for patients with heart-related conditions.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation